Urokinase -type plasminogen activator ( u -PA ) plays a key role in malignant tumor behavior. We have previously shown that the expression of high levels of u -PA mRNA in human hepatocellular carcinoma ( HCC ) biopsies was inversely correlated with the survival of the patients. In order to evaluate the involvement of u -PA in the invasive and infiltrating properties of HCC cells, the SKHep1C3 cell line was stably transfected with an expression vector containing the 5 0 portion ( 257 bp ) of u -PA cDNA in the antisense orientation. u -PA mRNA expression and its protein level and enzymatic activity were specifically inhibited in the antisense transfectants. A comparable inhibition of the u -PA receptor ( u -PAR ) mRNA and protein was also evidenced in the antisense transfected cells compared with the control ones. At the functional level, the SKHep1C3 -AS cells showed a significant reduction in proliferation, Matrigel invasion, and motility assays compared to parental and vector -alone cells. These results indicate that u -PA is an essential factor in the growth and invasiveness of human hepatocarcinoma cells. Antisense u -PA strategy might be a potential approach to reduce tumor growth as well as the invasive capacity of the malignant cells in HCC.
H epatocellular carcinoma (HCC ) is one of the most common malignancies in the world. The prognosis of this cancer is very poor. Tumor recurrence is a major cause of death, but the origin of recurrent HCCs remains an open question. Moreover, in liver with chronic hepatitis B and C virus infection, the cancer is sometimes detected as multiple HCCs, some of which are known to develop from a single clone as intrametastatic lesions.
1,2 Efficient tumor cell invasiveness, localized proteolysis, and secondary tumor formation (metastasis ) are associated with the release and activation of proteinases in the peritumoral microenvironment by tumor and /or stromal cells. 3, 4 Clinical findings and experimental evidence strongly indicate that urokinase -type plasminogen activator ( u-PA ) and its receptor ( u -PAR ) are linked to the degradation and remodeling of normal and cancer tissue and of the surrounding extracellular matrix ( ECM ). 4 -6 In many human primary tumors, high levels of u -PA and u -PAR expression are related to shortened patient survival. 7 Moreover, u -PA /u -PAR system is directly involved in cell migration and adhesion because u -PAR is able to interact with vitronectin ( VN ) and also with the b -subunit of some integrins. 8, 9 In addition to its role in the proteolysis of ECM components and also in cell adhesion to the ECM, u-PA, in association with its receptor, was found to be a mitogenic factor of several normal and tumor cell lines, transducing proliferative signals with or without its (serine ) protease domain. 10 -13 Therefore, plasminogen activation system (u -PA /u -PAR ) is considered a potential target for cancer therapy at different levels ( proteins and /or genes ) by antibodies, enzyme inhibitors, synthetic u -PA and u-PAR analogues, antisense oligonucleotides and antisense u-PA, and u -PAR stably transfected cDNA sequences. 14 We have previously studied the expression of u-PA, tissue -type plasminogen activator ( t-PA ), and u-PAR in control and tumoral human liver tissues, demonstrating that t -PA and u -PAR gene expression was up -regulated in all the HCCs tested and in most of the peritumoral tissues analyzed and that u-PA gene transcription was activated in HCC. 15 In addition, u -PA mRNA expression was significantly correlated with the expression of c -met proto -oncogene ( HGF receptor ) and their levels of expression were inversely correlated with patient survival. 16 In this study, we report the results of the highly malignant HCC cell line (SKHep1 ) following stable transfection with a vector expressing u-PA antisense RNA. The results of this study show that cellular proliferation, migration, and invasion of u -PA antisense transfected cells were significantly inhibited, and provide evidence that u-PA antisense might be an efficient strategy in decreasing HCC malignancy.
Methods

Cell lines
SK -Hep1Clone3 (SK -Hep1C3 ), selected from human hepatocellular carcinoma ( HCC ) cells ( SK -Hep1; ATCC HTB52), 17 and SK -Hep1C3 transfected cells were grown in Earle's MEM ( Gibco BRL /Life Technologies, Gaithersburg, MD ) with 10% FCS ( Seromed, Berlin, Germany ), 100 IU /mL penicillin, and 100 g/mL streptomycin ( Squibb, Rome, Italy ) at 378C in a 5% CO 2 incubator. SKHep1C3 was an SKHep1 subpopulation evidenced for its marked capacity to form large soft agar clones, to invade Matrigel matrix, and to express higher levels of u -PA and u-PAR mRNA compared to SKHep1 cells (data not shown ). Human fibrosarcoma cells (HT1080; ATCC CCL 121 ), as well as AB5 human dermal fibroblasts, 10 were also cultured in the same conditions.
Preparation of constructs
Total RNA was isolated from HT1080 fibrosarcoma cells using Trizol reagent (Gibco BRL /Life Technologies ) according to the manufacturer's instructions. One microgram of total RNA was reverse -transcribed using random hexamer primers, and the enzymatic reaction was performed essentially as described in Tavian et al. 18 One hundred nanograms of c-DNA was diluted with PCR buffer (50 mM KCl, 10 mM Tris -HCl, 2 mM MgCl 2 ) to a final volume of 50 L, which contained 50 pmol of a primer set for each reaction, additional dNTPs (0.8 mM final concentration ), and 2 U of Taq DNA polymerase ( Promega, Madison, WI ). The amplification reactions were performed using a Gene Amp PCR System 9600 (Perkin Elmer, Norwalk, CT, USA ).
A fragment of 257-bp cDNA corresponding to nucleotides 58 -314 of u -PA c-DNA was amplified using the synthetic primers u-PA FOR (5 0 -GACCTCGCCACCAT-GAGAG -3 0 ) and u-PA REV (5 0 -GCCTTTCCTCGGTA-AAAGTGAC -3 0 ) with the following cycle profile: denaturation at 958 for 60 seconds, annealing at 618 for 30 seconds, and extension at 728 for 45 seconds for the first round; denaturation at 958 for 30 seconds, annealing at 618 for 30 seconds, and extension at 728 for 45 seconds for 26 cycles; and denaturation at 958 for 30 seconds, annealing at 618 for 30 seconds, and terminal extension at 728 for 2 minutes for the last cycle. The specificity of polymeraseamplified PCR product was tested by digestion with CfoI restriction enzyme ( data not shown ). The 257-bp u-PA fragment was directly ligated into the eukaryotic pEF6 /V5 -His TOPO expression vector ( containing the blasticidineselectable marker gene and the human elongation factor 1a promoter ) and cloned in TOP10 chemically competent Escherichia coli, according to the manufacturer's instructions ( Invitrogen, Carlsbad, CA ). u -PA antisense construct orientation was verified by sequencing.
Transfection and selection
SKHep1C3 cells, seeded in 60 -mm dishes, were grown to semiconfluency and then transfected with 5 g of antisense pEF6 u-PA and pEF6 alone using DOTAP Liposomal transfection reagent according to the manufacturer's instructions ( Invitrogen ).
Selection started 48 hours after transfection by adding 6 g /mL blasticidine. The selection medium was changed every 4 days until all nonresistant cells died. Transfected cells (SKHep1C3 -V: cells transfected with vector-alone; SKHep1C3 -AS: cells transfected with u-PA antisense construct ) were expanded for subsequent experiments.
RT -PCR analysis
Total RNA of transfected SKHep1C3 was extracted and reverse -transcribed as described above. Integrity of RNA and adequate cDNA synthesis were confirmed using GAPDH1 / 2-specific primers. 19 In the transfected SKHep1C3 cells, the expression of antisense pEF6 u-PA construct was verified with the following pair of primers: T7 ( plasmid -specific sequence) and u -PA FOR ( Fig 1 ) .
Endogenous u-PA and u-PAR expression was detected by RT-PCR analysis with u -PA1 /u -PA2 and u-PAR1 / u -PAR2 primers. 15 A comparative PCR method was used to determine the percentage of inhibition of u-PA and u -PAR mRNA, together with an image analysis system (AIS ) able to scan the PCR -amplified products directly from the images of the agarose gel bands, thus obtaining a relative quantification of the u -PA and u -PAR cDNA products in comparison with a constant expression level of GAPDH.
The relative values were expressed in pixels as integrated density (ID ). 15 A quantification of the ribosomal protein L7, phosphoglycerate kinase 1 (PGK1 ), b -actin, p53, p21, c -met ( hepatocyte growth factor, HGF, receptor), III -9 fibronectin ( FN ), t -PA, and plasminogen activator inhibitor type I (PAI -1 ) expression was also performed using specific primers.
-21
Immunofluorescence
For the immunofluorescence detection of u -PA, u -PAR and GAPDH, SK -Hep1C3, and SK -Hep1C3 transfected cells were seeded ( 40,000 cells /22Â22 mm glass coverslips 
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Antisense u-PA transfection in hepatocarcinoma cells D Tavian et al in 3-cm Petri dishes) and treated according to the standard protocol described previously. 22 After reaching semiconfluency, the cultures were fixed in cold methanol ( 1Â20 minutes and 1Â10 minutes ) and, after one washing in PBS (1Â3 minutes ), they were treated with 1% BSA (for u-PA and GAPDH ) and 0.3% BSA in PBS for u-PAR detection (1Â3 minutes ) and then immunoreacted with the first antibodies, polyclonal antibodies antihuman u -PA (TechnoClone, Vienna, Austria ) (1:100 in diluting buffer containing 1% BSA in PBS ), anti -u -PAR (1:200 in 0.3% BSA in PBS ), and anti -GAPDH (Chemicon International, Temecula, CA ) ( 1:200 in 1% BSA in PBS ) for 30 minutes at room temperature. Mouse monoclonal anti -u -PAR antibodies were kindly provided by Prof Francesco Blasi ( DIBIT, Istituto Scientifico San Raffaele and Università Vita -Salute San Raffaele, Milan, Italy ). After one washing with PBS, cells were then immunoreacted with the secondary antibodies fluorescein -conjugated antirabbit IgG or rhodamineconjugated antimouse IgG ( 1:100 in diluting buffer ) for 30 minutes at room temperature (secondary antibodies from Calbiochem, San Diego, CA ). The coverslips were mounted on glass slides in mounting medium and photographed with a Leitz Fluorescence microscope ( magnification Â100 ). The Integrated Optical Density (IOD ) levels of 100 SKHep1C3, 100 SKHep1C3-V, and 100 SKHep1C3-AS cells was carried out on the cells following antiu -PA and anti -u -PAR IF staining. Ten randomly chosen fields were analysed for each cell type. All corresponding images were taken at the same exposure (magnification Â63 ), acquired with a Sony digital (charge-coupled ) device camera, and analysed by a specific program of AIS, which evaluates the IOD level of each immunofluorescent cell. Analysis of variance was performed considering SKHep1C3, SKHep1C3 -V and SKHep1C3 -AS u-PA, u -PAR, and GAPDH IOD levels. The data were considered to be significant when P .05.
Western blot analysis and zymography
The conditioned media ( CM) were prepared and analysed by Western blotting and zymography, as previously described. 22, 23 The 24-hour serum -free CM (2 mL /5 -cm Petridish ) were collected from confluent cultures of parental, vector, and antisense transfected cells. Constant amounts of proteins ( 0.5 g of CM from transfected and nontransfected cells ) were loaded in the presence of SDS, under nonreducing conditions, on a 4% / 6% /12 /% polyacrylamide gel in proportions of 2:3:4, respectively. The separated proteins were electroblotted onto a nitrocellulose membrane, then immunoblotted using polyclonal antibodies against human u -PA (TechnoClone) ( 1:1000 in 1% BSA ) to evaluate u -PA protein amount, or overlaid onto casein agar containing 2 g /mL human plasminogen ( TechnoClone ) to evaluate u -PA activity. 23 The cell extracts ( CEs ) were prepared as described 22, 23 from confluent cultures grown in serum -containing medium. 
Cancer Gene Therapy
Antisense u-PA transfection in hepatocarcinoma cells D Tavian et al
After extensive washing of the cultures with cold PBS, cells were recovered by scraping with a rubber policeman in 1 mL of 0.05% (wt /vol ) SDS. Constant amounts of proteins (27 g /well) were loaded in the presence of SDS, under nonreducing conditions, on a 8% polyacrylamide gel. The separated proteins were electroblotted onto a nitrocellulose membrane, then immunoblotted using rabbit polyclonal antibodies anti -protein kinase R (PKR ), anti -phospo -PKR ( Thr 446 /451 ), anti -eIF2a ( eIF2a: a subunit of eukaryotic initiation factor 2), anti -phospho -eIF2a (Ser51 ) ( Cell Signaling Technology, MA ) ( 1:1000 in 5% BSA ), and alkaline phosphatase -conjugated antirabbit IgG ( 1:7500 vol /vol ) and the positive immunoreaction detected with nitroblue tetrazolium and bromochloroindolyl phosphate ( Promega, San Diego, CA ).
Invasion and motility
Invasion and motility assays were performed in 24-well transwell chambers ( Costar, Bodenheim, Germany ). The upper and lower culture compartments were separated by polycarbonate filters with 8-m pores. Fifteen micrograms of Matrigel matrix (Becton Dickinson Labware, Bedford, MA ) was dispensed in transwell inserts and allowed to gel for 1 hour at 378C. Cells were added to coated filters (2Â10 5 cells/filter ) in 100 L of serum -free medium in triplicate wells. In the lower compartments of the chambers, a volume of 600 L of AB5 human fibroblast serum free -CM was used as chemoattractant. The plates were incubated at 378C in a 5% CO 2 incubator for 24 hours. At the end of the incubation period, the cells on the upper surface of the filter were wiped off using a cotton swab, fixed, and stained with Hema -3. Lastly, all the cells on the lower surface were photographed and counted.
The motility assay was conducted in a similar fashion without coating with Matrigel. Cells (1Â10 5 /filter ) were loaded on transwell polycarbonate membrane inserts (8 m pore size ) in triplicate wells. The plates were incubated for 24, 48, and 72 hours ( t 1 , t 2 , t 3 ) at 378C in a 5% CO 2 incubator. At the end of t 1 incubation, the transwell inserts were removed and the cells in the lower wells were fixed, stained with Hema -3, and counted. At the end of t 2 and t 3 incubation, the cells that migrated in the lower compartment of the chambers were trypsinized and counted. Each experiment was carried out in triplicate. The statistical significance of the results was calculated using the analysis of variance procedure. The data were considered to be significant when P .05. 
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Results
HCC SKHep1C3 cells were transfected with pEF6 /V5 -His TOPO expression vector containing 257 bp of the 5 0 portion of the u -PA cDNA (58 -314 nt ) in antisense orientation ( SKHep1C3 -AS ). Parental cells and cells transfected with the expression vector (SKHep1C3 -V ) were used as controls. Transfected cells were selected for blasticidine resistance and characterized by the presence and the expression of u-PA antisense sequence ( Fig 1 ) (see Methods ).
RT -PCR analysis of u -PA and u -PAR expression
Molecular characterization of parental (SKHep1C3 ) and transfected cells ( SKHep1C3-V and SKHep1C3-AS ) was carried out by RT-PCR analysis of u -PA and u -PAR expression. SKHep1C3 -AS cells showed a marked reduction in u -PA and u-PAR mRNA expression, whereas SKHep1C3 -V cells showed substantially the same levels of parental cell u -PA and u -PAR mRNA ( Fig 2, A and B ) . Conversely, the expression of other genes, such as c -met, p53, p21, FN, t -PA, and PAI -1, was not modulated by u -PA antisense transfection (data not shown ). GAPDH, ribosomal protein L7, b -actin, and PGK1 RT-PCR products were detectable in similar amounts in all cell lines tested ( Figs 2C and 3 ) . GAPDH RT-PCR products were used to normalize u-PA and u-PAR RT-PCR values for each sample ( Fig 2C ) .
Immunofluorescence analysis of u -PA and u -PAR protein expression
An immunofluorescence analysis with polyclonal anti -u -PA and monoclonal anti -u-PAR and GAPDH antibodies was performed to characterize the u-PA, u -PAR, and GAPDH protein content in nontransfected and transfected cells. As shown in Figure 4 , u-PA and u -PAR fluorescent protein signal of SKHep1C3-AS (C ) cells was strongly reduced compared to parental ( A ) and vector-alone ( B ) cell lines ( P .01). GAPDH immunofluorescent signals were similar in nontransfected and transfected cells ( Fig 4 ) ( Table 1 ) .
Immunoblotting and plasminogen zymography of u -PA
In order to determine whether antisense u -PA cDNA transfection affected u -PA protein secretion, constant protein amounts of CM from parental, vector, and antisense cells 
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Antisense u-PA transfection in hepatocarcinoma cells D Tavian et al were used to perform Western blotting analysis with polyclonal anti -u-PA antibodies. A specific protein band was present in all the samples and it was strongly reduced in the SKHep1C3 -AS CM (Fig 5A ) . The enzymatic activity of u -PA was assayed in CM from transfected and parental cells. Figure 5B shows that there was a significant difference in u -PA activity detected in CM of control cells ( SKHep1C3 and SKHep1C3 -V ) and antisense transfected cells ( SkHep1C3 -AS ). Western blotting analysis of PKR and phospho -PKR showed that this pathway was not activated by u-PA antisense transfection because PKR and phospho -PKR were detected in similar amount in nontransfected and transfected cells (Fig 6A ) . Also eIF2a, which belongs to PKR cell signaling pathway, was not activated in the u -PA antisense transfected cells ( Fig 6B ) .
Effect of u -PA antisense transfection on cell invasion, motility, and proliferation
In vitro invasion assay was designed to test whether transfection of antisense u-PA altered the invasive potential of tumor cells in Matrigel -coated transwell chamber. Cellular invasion of SKHep1C3-AS was lower than parental and vector-alone SKHep1C3 cell lines (Fig 7A ) . Out of 2Â10 5 cells seeded in each upper chamber compartment, average numbers of 5566 ( SD ± 321 ) and 4133 (SD ± 980) parental or vector-alone SKHep1C3 cells were detected on the lower sides of filters, as against 315 (SD ± 59 ) antisense transfected cells after 24 hours of incubation. Under these experimental conditions, the invasive potential of SKHep1C3 -AS cells appeared significantly reduced ( P <.001) ( Fig 7) .
In order to study the effect of antisense u-PA transfection on migration, parental and SKHep1C3 transfected cells were seeded on transwell chamber with uncoated filters, and the cells detectable on the lower sides of the filters were counted after 24, 48, and 72 hours of incubation. As shown in Figure  7A , after 24 hours of incubation, SKHep1C3 -AS cells were strongly inhibited in their motility potential when compared to parental and vector-alone transfected cells ( P <.001). Only about 5% of u -PA antisense transfected cells was able to migrate, considering 100% and 119% SKHep1C3 and SKHep1C3 -V migrated cells. Also, after 48 and 72 hours of incubation, cellular motility of u -PA antisense transfected cells was reduced ( P .05) (not shown ).
u -PA inhibition by antisense u -PA transfection modulated the proliferation of hepatocellular carcinoma cells. Cell proliferation was monitored by counting the cell number at various days (24, 48 , and 72 hours ) after seeding 50,000 cells / dish of transfected and nontransfected cells. As shown in Figure 7B , the proliferation of SKHep1C3-AS cells was markedly decreased compared to parental and vector -alone 
Discussion
Tumor growth and invasion are complex processes requiring networks of proteins such as growth factors, cytokines, chemokines, and proteases. Several studies have highlighted the importance of u-PA / u-PAR complex for cell adhesion, migration, localized proteolytic activity, and tissue invasion, both in physiological and in pathological conditions. Furthermore, several data point to a role for u -PA and u-PAR in signal transduction events regarding cell proliferation and cell migration. 3 -13,24,25 No studies have as yet been performed to evaluate the effects of the modulation of u-PA / u-PAR expression in human hepatocarcinoma cells. We have previously shown that u -PA gene transcription is up -regulated in human HCC tissues and that high levels of u-PA mRNA can be considered an unfavorable prognostic marker for HCC male patients. 15 In this work, we studied the SKHep1C3 hepatocarcinoma cell line, characterized by high levels of u-PA mRNA expression, to evaluate the biological effects of u-PA antisense stable expression strategy. The production and the secretion of u-PA were markedly reduced in antisense cells compared to control cells. The expression of a range of housekeeping genes was not affected by antisense u-PA transfection, indicating that this is a specific inhibition. The amount of u -PAR mRNA and protein, detected by RT-PCR and immunofluorescence analysis, was also shown to be less. A reduction in u -PAR was not observed in other studies on stable transfection of u -PA antisense constructs. 26, 27 Our results are in line with what is known about the ability of u -PA to up -regulate the expression of its cellular receptor at a transcriptional level, by increasing the activity of the transcriptional factor Sp1, and also at a posttranscriptional level, by promoting u -PAR mRNA stability. 28, 29 The drop in u -PA would, therefore, down -regulate the expression of its receptor as detected in our experimental system. The expression of other genes, which could be related to the u -PA phenotype, such as PAI -1, t -PA, FN, and c -met (HGF receptor ), was also tested. No difference in their expression level was observed in antisense u-PA tranfected cells.
The possible PKR and eIF2a activation in u -PA antisense transfected cells was excluded by immunoblotting analysis of their phosphorylated and unphosphorylated forms. The results indicated that u -PA and u -PAR protein reduction was not due to a nonspecific inhibition of translation through the PKR pathway.
In the present study, the modulation of u -PA mRNA, protein, and enzymatic activity affected the expression of u -PAR and determined a strong inhibition of migration and invasion in highly malignant liver cells. These findings are consistent with published results obtained with u -PA and u -PAR antisense constructs, antisense oligonucleotides, or anticatalytic antibodies in other cell lines. 26,27,30 -32 Invasive potential depends mainly on the cells' ability to promote the degradation of ECM and of basement membrane (BM ). Our results of the Matrigel assay showed that u-PA /u -PAR complex played a crucial role in invasion through this artificial matrix containing a mixture of ECM and BM components. The significantly reduced u-PA proteolytic activity detected in the CM of antisense transfected cells could be associated with their reduced invasive potential. Moreover, u -PA /u -PAR complex is linked to cellular migration through its ability to promote pericellular proteolysis, to regulate integrin function, and to interact with VN. 33, 34 It has been shown that u -PAR may bind physically to integrins in a reversible manner. Recent data suggest that u-PAR is able to assemble an active signaling complex involving u-PA, FN, and a5b1 (through EGFR, ERK1/ 2, and MAPK activation ) in the tumorigenic Hep3 cell line. 35 u -PAR can also complex with a3b1 integrin, promoting direct (VN ) and indirect (FN, Col ) pathways of cellular adhesion and migration in human breast carcinoma cell line MDA -MB -23. 36 We tested SKHep1C3 hepatocarcinoma cells for motility and we observed that the inhibition of u-PA / u-PAR complex dramatically affected their ability to migrate in in vitro assay. Some experiments, in which human epidermoid carcinoma cells (Hep3 ) were inoculated onto the chorioallantoic membrane of chick embryos, were performed to demonstrate the importance of u-PA and 
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Antisense u-PA transfection in hepatocarcinoma cells D Tavian et al u -PAR for tumor cell migration or invasion in the in vivo model system. 30, 32, 37 More recently, the same authors have shown that by blocking u -PAR expression with a vector expressing u-PAR antisense mRNA, the antisense Hep3 tumor cells altered the phenotype from tumorigenic to dormant. They also demonstrated that the mechanism responsible for dormancy was a diminished proliferation. 32, 35 There is considerable evidence that u-PA plays a role in tumor cell proliferation. 32,35 -38 In most experimental models, the binding of u-PA to u-PAR activates a5b1 and causes downstream ERK /MAP kinase activation. This is important not only for promoting cellular proliferation, but also for suppressing apoptosis. 39 In our study, we observed that u-PA antisense transfected cells were characterized by reduced proliferation. The growth factor activity of u-PA could be directly due to its ability to trasduce mitogenic signals to the nucleus, as recently demonstrated for other tumor and control cell lines, or indirectly, by activating the HGF, which is a mesenchymal -derived polypeptide, first identified as a potent mitogen for adult human and rat hepatocytes. 40, 41 We have verified that SKHEp1C3 cells do not express HGF mRNA, according to their epithelial origin; therefore, u -PA /u -PAR interaction very likely provided an autocrine mitogenic stimulus for these tumor cells. In a previous work, we showed that u-PA and c-met mRNA expression were coordinately enhanced in human HCC. 16 Other authors have demonstrated that the transcription of Ets -1, c-met, and u -PA was closely related and that it was involved in the invasive behavior of hepatoma cell lines. 42 As reported, we did not observe a down -regulation of c -met mRNA in u-PA antisense transfected cells.
In the last 5 years, the clinical significance of urokinase plasminogen activator and its receptor in HCC has been clearly defined, attesting that the increased expression of u-PA /u -PAR complex is related to HCC invasiveness, metastasis, and prognosis. 15,16,43 -46 Overall, the findings of this study demonstrate the effects of the u -PA /u -PAR system on cellular proliferation, motility, and invasion of malignant liver cells, suggesting the possibility of reducing hepatic tumor growth and intrahepatic metastasis formation in vivo by means of u -PA /u -PAR down -regulation.
